Test Price
4,800 AED✅ Home Collection Available
Gastro-Intestinal Cancer Gene Panel in UAE – 4800 AED | DNA Labs UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by a certified medical genetics team.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The Gastro-Intestinal Cancer Gene Panel is a cutting-edge next-generation sequencing (NGS) test that simultaneously analyzes multiple genes linked to hereditary gastrointestinal cancers, including colorectal, stomach, and pancreatic malignancies. This panel provides a comprehensive assessment of inherited risk, enabling informed decisions regarding prevention, surveillance, and early intervention strategies.
| Feature | Our Test (NGS Panel) | Closest Alternative (Single-Gene Testing) |
|---|---|---|
| Precision | >99.9% analytic sensitivity for target regions | Limited to one gene; may miss oligogenic risk |
| Method | Next Generation Sequencing (NGS) | Sanger sequencing or PCR |
| Speed | 4–6 weeks comprehensive report | 4–8 weeks per gene; serial testing extends total time |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
“As your clinical partner, I must emphasize that genetic test results require careful clinical correlation. This panel provides vital insights into your risk for gastrointestinal cancers, but it is not diagnostic. Please discuss all findings with your oncologist or primary care physician to create a personalised prevention and surveillance strategy based on your complete medical and family history.”
Advisory Information
Important Clinical Advisory
This test is designed for hereditary cancer risk assessment only. It does not replace routine cancer screening, diagnostic procedures, or urgent medical evaluation. Do not discontinue any prescribed medications or screening protocols without consulting your treating physician.
Exclusion Criteria & Red Flags
Exclusion Criteria & Emergency Red Flags
- Exclusions: Not recommended during active chemotherapy or radiation therapy (may compromise DNA quality). Wait at least 2 weeks after acute infection or blood transfusion. Pregnant women and minors require specialist referral and genetic counseling prior to testing.
- Emergency Red Flags: Seek immediate medical attention if you experience sudden weight loss, persistent severe abdominal pain, vomiting blood, or black tarry stools. This test is not a replacement for urgent clinical evaluation.
Patient FAQ & Clinical Guidance
1. What is the Gastro-Intestinal Cancer Gene Panel?
This advanced genetic test screens for inherited mutations linked to stomach, colorectal, and pancreatic cancers. It employs next-generation sequencing to thoroughly evaluate multiple cancer-predisposing genes simultaneously, delivering a lifetime risk assessment for you and your family.
2. Who should consider this test?
Individuals with a personal or family history of gastrointestinal cancers, multiple primary cancers, or early-onset cancer should consider testing. Genetic evaluation is also appropriate for those seeking to understand inherited cancer syndrome risks and guide intensified screening protocols.
3. How is the test performed and what is the turnaround time?
A simple peripheral blood sample is collected via our VIP mobile phlebotomy service at your home. Results are delivered within 4–6 weeks. Our service ensures cold-chain integrity throughout transport, and you receive a comprehensive oncology report interpreted by certified medical geneticists.
4. Will my insurance cover this genetic panel?
Coverage varies by insurance provider and policy. We offer direct billing verification via WhatsApp at +971 54 548 8731. Contact our billing team to confirm your eligibility and any pre-authorization requirements.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance: DNA Labs UAE operates under DHA Facility License Number 1143. All genetic testing services comply with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. Your genetic data is encrypted, stored securely, and never shared without your explicit written consent.
Clinical & Logistical Metadata
| Test Name | Gastro-Intestinal Cancer Gene Panel |
| Price (AED) | 4,800 AED |
| Turnaround Time | 4–6 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood |
| Methodology Used | Next Generation Sequencing (NGS) |
| ICD-10-CM Code | Z15.09 (Genetic susceptibility to other malignant neoplasm) |
| LOINC Code | 93035-9 (Hereditary cancer panel) |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians